Therapeutic Indications

Carbocisteine is indicated for:

Viscid mucoid secretions

Irrespective of gender only Children (1 year - 12 years old)

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 180-750 mg in 3 divided doses daily

Viscid mucoid secretions

Irrespective of gender only Adolescents (12 years - 18 years old) , Adults (18 - 65 years old)

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1500-2250 mg daily

Contraindications

Active ingredient Carbocisteine is contraindicated in the following cases:

Active peptic ulceration

No gender/age discrimination

Carbocisteine is contraindicated in patients with active peptic ulceration. Caution is recommended in the elderly, in those with a history of gastroduodenal ulcers, or those taking concomitant medications known to cause gastrointestinal bleeding. Since mucolytics may disrupt the gastric mucosal barrier, caution should be taken in patients with a history of peptic ulcers. If gastrointestinal bleeding occurs, patients should discontinue medication.